[
    [
        {
            "time": "2021-05-28",
            "original_text": "UPDATE 1-Chile approves Pfizer/BioNTech vaccine for teenagers in race to herd immunity target",
            "features": {
                "keywords": [
                    "Chile",
                    "Pfizer/BioNTech",
                    "vaccine",
                    "teenagers",
                    "herd immunity"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-28",
            "original_text": "Chilean health regulator approves Pfizer COVID-19 vaccine for teenagers",
            "features": {
                "keywords": [
                    "Chilean",
                    "health",
                    "regulator",
                    "Pfizer",
                    "COVID-19",
                    "vaccine",
                    "teenagers"
                ],
                "sentiment_score": 0.65,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-28",
            "original_text": "10 Best Dividend Stocks for Roth IRA",
            "features": {
                "keywords": [
                    "Best",
                    "Dividend",
                    "Stocks",
                    "Roth",
                    "IRA"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-05-28",
            "original_text": "Pfizer (PFE) COVID-19 Vaccine Gets Nod for Adolescents in EU",
            "features": {
                "keywords": [
                    "Pfizer",
                    "PFE",
                    "COVID-19",
                    "Vaccine",
                    "Adolescents",
                    "EU"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-28",
            "original_text": "EU Approves Pfizer-BioNTech COVID-19 Vaccine for Adolescents",
            "features": {
                "keywords": [
                    "EU",
                    "Pfizer-BioNTech",
                    "COVID-19",
                    "Vaccine",
                    "Adolescents"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-28",
            "original_text": "Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now",
            "features": {
                "keywords": [
                    "$500",
                    "Absurdly",
                    "Cheap",
                    "Stocks",
                    "Long-Term",
                    "Investors",
                    "Buy",
                    "Right",
                    "Now"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 3,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]